218 / 1224
56-year old male with metastatic
melanoma
•
IL-2
•
Ipilumimab
•
Re-induction Ipilimumab
•
Temodal
•
Activated T-cells
•
January 2-6, 2015: Palliative RT
20 Gy/4 frx
•
January 20, 2015 Pembrolizumab
•
Still without progression
05-01-2015
27-04-2015